Abstract
Patients presenting with RA before the age of 45 years (younger onset) are known to have more aggressive disease compared with patients presenting after the age of 65 years (older onset). Coordinated expansion of circulating CD5+ B cell and TCR γδ+ T cell levels has been reported in patients with RA. This study assesses the peripheral blood levels of these two cell types in RA patients with younger and older onset of disease. CD5+ B cell levels were significantly elevated in the younger onset RA group (26·6 ± 4·5%) compared with the older onset RA group (14·2 ± 1·2%; P <0·01). TCR γδ+ T cell levels were also significantly raised in the young patients (4·0 ± 0·9%) compared with elderly patients (1·6 ± 0·2%; P <0·01). T cell levels (CD3+) were similar in both groups (young 66·4 ± 3·3%; old 74·3 ± 3·4% (mean ± s.e.m.); NS). Total B cell levels (CD19+) were also similar in these groups (7·7 ± 0·7% versus 8·9 ± 1·8%; NS). A significant positive correlation was observed between the CD5− B and TCR γδ+ T cell types in the patients (r = 0·72, P <0.05). Compared with age-matched normal controls, the younger onset patients had similar CD5+ B cell and TCR γδ+ T cell levels to the elderly controls (CD5+ B cells 30·2 ± 3·0%; TCR γδ+ T cells 3·0 ± 0·8%). Conversely, older onset RA patients had CD5+ B cell levels similar to the young controls (12·3 ± 1·9%). Spontaneous in vitro synthesis of immunoglobulins (IgM, IgA and IgG) and rheumatoid factors (IgM and IgA isotypes) were not significantly different in both patient groups. The coordinate expansion of circulating CD5+ B cells and γδ+ T cells seen in patients with RA presenting before 45 years of age and not after 65 years of age may suggest a potential role for these cells in more aggressive disease states.
Keywords: rheumatoid arthritis, younger onset, CD5+ B cells, TCR γδ+ T cells
Full Text
The Full Text of this article is available as a PDF (396.9 KB).
References
- 1.Gadol N, Ault KA. Phenotypic and functional characterisation of human Leu-1 (CD5) B-cells. Immunol Rev. 1986;93:23–24. doi: 10.1111/j.1600-065x.1986.tb01500.x. [DOI] [PubMed] [Google Scholar]
- 2.Welsh MJ, Fong S, Vaughan J, Carson DA. Increased frequency of rheumatoid factor precursor B lymphocytes after immunization of normal adults with tetanus toxoid. Clin Exp Immunol. 1983;51:299–304. [PMC free article] [PubMed] [Google Scholar]
- 3.Casali P, Notkins AL. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today. 1989;10:364–8. doi: 10.1016/0167-5699(89)90268-5. [DOI] [PubMed] [Google Scholar]
- 4.Plater-Zyberk C, Maini RN, Lam K, Kennedy TD, Janossy G. A rheumatoid arthritis B-cell subset express a phenotype similar to that in chronic lymphocytic leukaemia. Arthritis Rheum. 1985;28:971–6. doi: 10.1002/art.1780280903. [DOI] [PubMed] [Google Scholar]
- 5.Rème T, Portier M, Frayssinoux F, et al. T-cell receptor expression and activation of synovial lymphocyte subsets in patients with rheumatoid arthritis. Arthritis Rheum. 1990;33:485–92. doi: 10.1002/art.1780330404. [DOI] [PubMed] [Google Scholar]
- 6.Holoshitz J, Koning F, Coligan JE, De Bruyn J, Strober S. Isolation of CD4− CD8− mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid. Nature. 1989;339:226–9. doi: 10.1038/339226a0. [DOI] [PubMed] [Google Scholar]
- 7.Haregewoin A, Soman G, Hom RC, Finberg RW. Human γδ T-cells respond to mycobacterial heat-shock protein. Nature. 1989;340:309–12. doi: 10.1038/340309a0. [DOI] [PubMed] [Google Scholar]
- 8.Healey LA. Rheumatoid arthritis in the elderly. Clinics Rheum Dis. 1986;12:173–9. [PubMed] [Google Scholar]
- 9.Brennan F, Plater-Zyberk C, Maini RN, Feldmann M. Coordinate expansion of ‘fetal type’ lymphocytes (TCRγδ+ T and CD5+ B) in rheumatoid arthritis and primary Sjögren's syndrome. Clin Exp Immunol. 1989;77:175–8. [PMC free article] [PubMed] [Google Scholar]
- 10.Arnett FC, Edworth SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
- 11.Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest. 1968;32:77. [PubMed] [Google Scholar]
- 12.Hassan J, Hanly J, Bresnihan B, Feighery C, Whelan A. The immunological consequences of gold therapy: a prospective study in patients with rheumatoid arthritis. Clin Exp Immunology. 1986;63:614–20. [PMC free article] [PubMed] [Google Scholar]
- 13.Burastero SE, Casali P, Wilder RL, Notkins AL. Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis. J Exp Med. 1988;168:1979–92. doi: 10.1084/jem.168.6.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Hardy RR, Hayakawa K, Shimizu M, Yamasaki K, Kischimoto T. Rheumatoid factor secretion from human Leu-1+ B-cells. Science. 1987;236:81–83. doi: 10.1126/science.3105057. [DOI] [PubMed] [Google Scholar]
- 15.Casali P, Burastero SE, Nakamura M, Inghirami G, Notkins AL. Human lymphocytes making rheumatoid factors and antibody to ssDNA belong to Leu-1+ B-cell subset. Science. 1987;236:76–81. doi: 10.1126/science.3105056. [DOI] [PubMed] [Google Scholar]
- 16.Karsh J, Goldstein R, Lazarovits AI. In vitro IgM and IgM rheumatoid factor production in response to Staphylococcus aureus Cowan I and pokeweed mitogen: the contribution of CD5+ (Leu1) B cells. Clin Exp Immunol. 1989;77:179–83. [PMC free article] [PubMed] [Google Scholar]
- 17.Hassan J, Feighery C, Bresnihan B, Whelan A. Effect of gold therapy on CD5+ B-cells and TCRγδ+ T-cells in patients with rheumatoid arthritis. Rheumatol Int. 1991;11:175–8. doi: 10.1007/BF00332557. [DOI] [PubMed] [Google Scholar]
- 18.Giachino C, Granziero L, Modena V, et al. Clonal expansions of Vδ1+ and Vδ2+ cells increase with age and limit the repertoire of human γδ T cells. Eur J Immunol. 1994;24:1914–8. doi: 10.1002/eji.1830240830. [DOI] [PubMed] [Google Scholar]